564 related articles for article (PubMed ID: 15940622)
1. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease.
Maul J; Loddenkemper C; Mundt P; Berg E; Giese T; Stallmach A; Zeitz M; Duchmann R
Gastroenterology; 2005 Jun; 128(7):1868-78. PubMed ID: 15940622
[TBL] [Abstract][Full Text] [Related]
2. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
Kelsen J; Agnholt J; Hoffmann HJ; Rømer JL; Hvas CL; Dahlerup JF
Clin Exp Immunol; 2005 Sep; 141(3):549-57. PubMed ID: 16045746
[TBL] [Abstract][Full Text] [Related]
3. Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma.
Klein S; Kretz CC; Ruland V; Stumpf C; Haust M; Hartschuh W; Hartmann M; Enk A; Suri-Payer E; Oberle N; Krammer PH; Kuhn A
Ann Rheum Dis; 2011 Aug; 70(8):1475-81. PubMed ID: 21097800
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment.
Veltkamp C; Anstaett M; Wahl K; Möller S; Gangl S; Bachmann O; Hardtke-Wolenski M; Länger F; Stremmel W; Manns MP; Schulze-Osthoff K; Bantel H
Gut; 2011 Oct; 60(10):1345-53. PubMed ID: 21459928
[TBL] [Abstract][Full Text] [Related]
5. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.
Yu QT; Saruta M; Avanesyan A; Fleshner PR; Banham AH; Papadakis KA
Inflamm Bowel Dis; 2007 Feb; 13(2):191-9. PubMed ID: 17206665
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease.
Wang Y; Liu XP; Zhao ZB; Chen JH; Yu CG
J Dig Dis; 2011 Aug; 12(4):286-94. PubMed ID: 21791023
[TBL] [Abstract][Full Text] [Related]
7. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.
Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S
Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227
[TBL] [Abstract][Full Text] [Related]
8. Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease.
Lord JD; Shows DM; Chen J; Thirlby RC
PLoS One; 2015; 10(8):e0136485. PubMed ID: 26305224
[TBL] [Abstract][Full Text] [Related]
9. Role of miR-22 in intestinal mucosa tissues and peripheral blood CD4+ T cells of inflammatory bowel disease.
Pei XF; Cao LL; Huang F; Qiao X; Yu J; Ye H; Xi CL; Zhou QC; Zhang GF; Gong ZL
Pathol Res Pract; 2018 Aug; 214(8):1095-1104. PubMed ID: 29880327
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab.
Li Z; Arijs I; De Hertogh G; Vermeire S; Noman M; Bullens D; Coorevits L; Sagaert X; Schuit F; Rutgeerts P; Ceuppens JL; Van Assche G
Inflamm Bowel Dis; 2010 Aug; 16(8):1299-310. PubMed ID: 20196149
[TBL] [Abstract][Full Text] [Related]
11. Involvement of CD4+CD25+ regulatory T cells in the pathogenesis of polycythaemia vera.
Zhao WB; Li Y; Liu X; Zhang LY; Wang X
Chin Med J (Engl); 2008 Sep; 121(18):1781-6. PubMed ID: 19080357
[TBL] [Abstract][Full Text] [Related]
12. Peripheral and Intestinal T-regulatory Cells are Upregulated in Children with Inflammatory Bowel Disease at Onset of Disease.
Sznurkowska K; Żawrocki A; Sznurkowski J; Zieliński M; Landowski P; Plata-Nazar K; Iżycka-Świeszewska E; Trzonkowski P; Szlagatys-Sidorkiewicz A; Kamińska B
Immunol Invest; 2016 Nov; 45(8):787-796. PubMed ID: 27759462
[TBL] [Abstract][Full Text] [Related]
13. Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients.
Tsunemi S; Iwasaki T; Imado T; Higasa S; Kakishita E; Shirasaka T; Sano H
AIDS; 2005 Jun; 19(9):879-86. PubMed ID: 15905668
[TBL] [Abstract][Full Text] [Related]
14. Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients.
Wang X; Zheng J; Liu J; Yao J; He Y; Li X; Yu J; Yang J; Liu Z; Huang S
Eur J Haematol; 2005 Dec; 75(6):468-76. PubMed ID: 16313258
[TBL] [Abstract][Full Text] [Related]
15. Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases.
Boschetti G; Nancey S; Sardi F; Roblin X; Flourié B; Kaiserlian D
Inflamm Bowel Dis; 2011 Jan; 17(1):160-70. PubMed ID: 20848510
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients.
Lorea Baroja M; Kirjavainen PV; Hekmat S; Reid G
Clin Exp Immunol; 2007 Sep; 149(3):470-9. PubMed ID: 17590176
[TBL] [Abstract][Full Text] [Related]
17. Intestinal lamina propria retaining CD4+CD25+ regulatory T cells is a suppressive site of intestinal inflammation.
Makita S; Kanai T; Nemoto Y; Totsuka T; Okamoto R; Tsuchiya K; Yamamoto M; Kiyono H; Watanabe M
J Immunol; 2007 Apr; 178(8):4937-46. PubMed ID: 17404275
[TBL] [Abstract][Full Text] [Related]
18. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells.
Vieira PL; Christensen JR; Minaee S; O'Neill EJ; Barrat FJ; Boonstra A; Barthlott T; Stockinger B; Wraith DC; O'Garra A
J Immunol; 2004 May; 172(10):5986-93. PubMed ID: 15128781
[TBL] [Abstract][Full Text] [Related]
19. Decrease in CD4+CD25+FoxP3+ Treg cells after pulmonary resection in the treatment of cavity multidrug-resistant tuberculosis.
Wu YE; Peng WG; Cai YM; Zheng GZ; Zheng GL; Lin JH; Zhang SW; Li K
Int J Infect Dis; 2010 Sep; 14(9):e815-22. PubMed ID: 20655262
[TBL] [Abstract][Full Text] [Related]
20. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
